NovaBay Pharmaceuticals, Inc. (NBY): Price and Financial Metrics
NovaBay Pharmaceuticals, Inc. (NBY)
Today's Latest Price: $0.61 USD
Updated Oct 30 8:00pm
Add NBY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NBY Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for NBY is 9.35 -- better than 96.57% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 10.72 for NovaBay Pharmaceuticals Inc; that's greater than it is for 94.09% of US stocks.
- With a year-over-year growth in debt of -69.39%, NovaBay Pharmaceuticals Inc's debt growth rate surpasses merely 3.38% of about US stocks.
- If you're looking for stocks that are quantitatively similar to NovaBay Pharmaceuticals Inc, a group of peers worth examining would be HBB, WTER, APAM, KIRK, and SYPR.
- NBY's SEC filings can be seen here. And to visit NovaBay Pharmaceuticals Inc's official web site, go to www.novabay.com.
NBY Stock Price Chart Interactive Chart >
NBY Price/Volume Stats
| Current price | $0.61 | 52-week high | $1.94 |
| Prev. close | $0.62 | 52-week low | $0.24 |
| Day low | $0.60 | Volume | 396,427 |
| Day high | $0.63 | Avg. volume | 3,548,252 |
| 50-day MA | $0.77 | Dividend yield | N/A |
| 200-day MA | $0.85 | Market Cap | 25.36M |
NovaBay Pharmaceuticals, Inc. (NBY) Company Bio
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products for the eye care market in the United States. The company was founded in 2000 and is based in Emeryville, California.
Loading social stream, please wait...